Attention Deficit Hyperactivity Disorder

Ritalin Use in Maryland Schools Lowest for Minorities, Highest for Special Education

Published in Medical Letter on the CDC and FDA, September 24th, 2000

Nearly 3% of Maryland public school students receive medication, most commonly the methylphenidate trademarked Ritalin, during school hours for treatment of attention deficit hyperactivity disorder (ADHD), according to a Maryland State Department of Education-supervised survey of school nurses.

Published in the September 2000 issue of Pediatrics, the findings note significant disparities in the treatment rate for minority children and a concentrated use of ADHD medications among children receiving special education services.

The Maryland General Assembly's Legislative Task Force for the Study of the Use of Methylphenidate and Other Drugs...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-09-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry